Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Siege Of Mumbai Affects Workers At Two Japanese Pharmas In India

This article was originally published in PharmAsia News

Executive Summary

The terrorist siege of Mumbai, India, disrupted employee travel for several drug makers, including Daiichi Sankyo and Astellas Pharma. Both Japanese drug makers have subsidiaries based in India's financial capital. Daiichi ordered its employees on business trips to the area to return to Japan, while Astellas' few workers in a nascent marketing firm in the city were instructed to stay home. Several Daiichi personnel were in Mumbai to establish ties with Ranbaxy Laboratories, which Daiichi is converting into a subsidiary after buying the firm. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts